Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270512 · ClinicalTrials.gov registry record · NA
Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions
A NA study of Skin Lesion, sponsored by R2 Dermatology.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 4
- Study locations
NCT05270512: Completed NA study of Skin Lesion, sponsored by R2 Dermatology.
NCT05270512 is a NA study of Skin Lesion that has completed, run by R2 Dermatology. The registered enrollment target is 88 participants, below the 1,769-participant average among 3 other Skin Lesion trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05270512, a NA study of Skin Lesion, has completed, sponsored by R2 Dermatology.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate whether the Dermal Cooling System can be used to elicit an improvement in the cosmetic appearance or physical symptoms of common skin conditions.
Primary Outcome
Investigator assessment using Physician Global Assessment (PGA); graded from "4" (very much improved") to "0" (worse).
Conditions Studied
Interventions
- DEVICE Dermal Cooling System
Study Locations (4)
California
- West Coast Research - Dublin
Illinois
- Oak Dermatology - Naperville
New York
- Skin Search of Rochester, Inc. - Rochester
North Carolina
- Dermatology, Laser and Vein Specialists of the Carolinas - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2021-12-10 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
What the finished NCT05270512 record still lists
NCT05270512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,769-participant average among 3 other Skin Lesion trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Skin Lesion appearing as the primary indexed condition, and to 1 intervention - of which Dermal Cooling System is the first listed.
NCT05270512 reports a single indexed study location in California, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT05270512 about?
NCT05270512 is a clinical study titled "Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions". The purpose of this study is to evaluate whether the Dermal Cooling System can be used to elicit an improvement in the cosmetic appearance or physical symptoms of common skin conditions.
What is the current status of trial NCT05270512?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2021-12-10. Estimated completion is 2023-11-01.
What conditions does trial NCT05270512 study?
This clinical trial studies the following conditions: Skin Lesion.
What interventions are being tested in trial NCT05270512?
The interventions under investigation include: Dermal Cooling System (DEVICE).
Who is sponsoring clinical trial NCT05270512?
This trial is sponsored by R2 Dermatology, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05270512 being conducted?
This trial has 4 study locations across California, Illinois, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Lesion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI